Loading…

Novartis announced a $23 billion investment over 5 years to expand its US manufacturing and R&D footprint, including 7 new facilities and expansions at 3 existing sites, creating nearly 1,000 jobs at Novartis.
“Today, Novartis, a leading global innovative medicines company, announced a planned $23 billion investment over 5 years in US-based infrastructure, ensuring all key Novartis medicines for US patients will be made in the United States.”novartis.com
Summarized from public sources; check the original articles before acting on it.